ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 191 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $153,000 | +35.4% | 3,577 | +14.0% | 0.00% | 0.0% |
| Q3 2019 | $113,000 | +197.4% | 3,137 | +118.6% | 0.00% | – |
| Q2 2019 | $38,000 | -68.9% | 1,435 | -68.4% | 0.00% | -100.0% |
| Q1 2019 | $122,000 | +74.3% | 4,547 | +3.1% | 0.00% | 0.0% |
| Q4 2018 | $70,000 | -32.7% | 4,412 | -11.2% | 0.00% | 0.0% |
| Q3 2018 | $104,000 | +82.5% | 4,967 | +33.8% | 0.00% | 0.0% |
| Q2 2018 | $57,000 | -40.6% | 3,713 | -13.5% | 0.00% | 0.0% |
| Q1 2018 | $96,000 | -30.9% | 4,291 | -6.6% | 0.00% | -50.0% |
| Q4 2017 | $139,000 | +8.6% | 4,596 | +36.1% | 0.00% | 0.0% |
| Q3 2017 | $128,000 | +36.2% | 3,376 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $94,000 | +42.4% | 3,376 | +76.2% | 0.00% | +100.0% |
| Q1 2017 | $66,000 | +1550.0% | 1,916 | +1194.6% | 0.00% | – |
| Q4 2016 | $4,000 | -84.6% | 148 | -81.4% | 0.00% | -100.0% |
| Q3 2016 | $26,000 | +23.8% | 795 | +9.8% | 0.00% | 0.0% |
| Q2 2016 | $21,000 | – | 724 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 27,228,338 | $611,821,000 | 5.19% |
| First Washington CORP | 176,950 | $3,976,000 | 2.06% |
| SECTORAL ASSET MANAGEMENT INC | 783,424 | $17,604,000 | 1.93% |
| HARVEY CAPITAL MANAGEMENT INC | 219,042 | $4,921,000 | 1.84% |
| Ghost Tree Capital, LLC | 400,000 | $8,988,000 | 1.82% |
| Opus Point Partners Management, LLC | 36,733 | $825,000 | 1.62% |
| Palo Alto Investors LP | 1,650,780 | $37,093,000 | 1.59% |
| EMORY UNIVERSITY | 84,714 | $1,904,000 | 1.36% |
| GARRISON BRADFORD & ASSOCIATES INC | 69,000 | $1,550,000 | 1.32% |
| HealthCor Management, L.P. | 1,378,000 | $30,964,000 | 1.05% |